ã¦ã¤ã«ã¹ãã¯ã¯ãã³é¢é£è¨äºã®ç¬¬ï¼å¼¾ã§ãã ð¥æ°åã³ããã®ãã³ãããã¯ã§ãæ°ãã«ç»å ´ããæ¦å¿µãã·ã§ãã£ã³ã°ã§ãã ã·ã§ãã£ã³ã°ã¨ã¯ããã³ããã¯ã¯ãã³æ¥ç¨®è ããéæ¥ç¨®è ã¸ã®ã¯ã¯ãã³ã®æåã®ä¼æãã¨å®ç¾©ããã¦ããããã§ãã ã³ããã¯ã¯ãã³ã®æ¥ç¨®è ããä½ããã®æåãæ¾åºãããæ¥è§¦ããã¯ã¯ãã³éæ¥ç¨®è ã«ãã®æåãå ¥ãè¾¼ã¿ç®ã®çã¿ã鼻水ãã¢ã¬ã«ã®ã¼ãé ççã諸ã ã®çç¶ã表ãããã¨ãããã®ã§è¢«å®³è ã¯å¤æ°ã«åãã§ããããã§ãã ãã¡ãããæ¿åºãåå´çã¯ã·ã§ãã£ã³ã°ãèªãã¦ãã¾ããã ç§èªèº«ãå®éãã·ã§ãã£ã³ã°ã«éã£ã人ãæ°äººã¨ä¼ãã¾ããããèªèº«ãã·ã§ãã£ã³ã°ã®ãããªçç¶ãæãããã¨ãããã¾ãã ã·ã§ãã£ã³ã°ã«ã¤ãã¦ã¯ãåå ã¯ã¹ãã¤ã¯ã¿ã³ãã¯è³ªãããªãªã³ãæ¾å°ç·è¢«æçãããããè¨ããã¦ãã¾ãã ã·ã§ãã£ã³ã°ã®çã®åå ã¯ä½ã§ããããï¼ ããã¯ãä¸è¨ã§è¨ãã¨éªæ°ã§ããã¨ç§ã¯èãã¦ãã¾ãã ãã¾ããéªæ°ãï¼ã
æææ å ± ã·ã§ãã£ã³ã°ãããèã¿ã³ãã¯è³ªãé¸ã³åºãä»çµã¿ã解æâè² ã®é»è·ãæã¤ã¢ããé ¸ãã·ã§ãã£ã³ã°ãé»å®³ããâ ç«å½é¤¨å¤§å¦çå½ç§å¦é¨ã®ç½å£æåææãã®ç 究ã°ã«ã¼ãã¯ãæ±äº¬å»ç§æ¯ç§å¤§å¦ãä¹å·å¤§å¦ã大éªå¤§å¦ã¨ã®å ±åç 究ã§ãèããã±ã質ã®ç¹å®ã®é åã®ã¢ããé ¸é åãç´°èå¤ãã¡ã¤ã³ã·ã§ãã£ã³ã°ï¼ä»¥ä¸ãã·ã§ãã£ã³ã°ï¼ã«å¯¾ããæåæ§ã決ãã¦ãããã¨ã解æãããã¾ãããæ¬ç 究ææã¯ãå¦è¡èªãJournal of Biological Chemistryãã§çºè¡¨ããæ¡æç2ï¼ ç¨åº¦ã§ããEditors' Picksã«ãé¸åºããã¾ãããæ¬ç 究ã¯ãå½ç«ç 究éçºæ³äººæ¥æ¬å»çç 究éçºæ©æ§ã®é©æ°çå 端ç 究éçºæ¯æ´äºæ¥ï¼AMED-CRESTï¼ãçä½æ常æ§ç¶æã»å¤å®¹ã»ç ´ç¶»æ©æ§ã®ãããã¯ã¼ã¯çç解ã«åºã¥ãæé©å»çå®ç¾ã®ããã®æè¡åµåºãç 究éçºé åã«ãããç 究éçºèª²é¡ãç´°èéç¸äºä½ç¨ã¨èå¨ä»£è¬ãããã¯ã¼ã¯ã®ç ´ç¶»ã«ããçµç¹ç·ç¶
Meiji Seika ãã¡ã«ããåå£ä¸ååè¡é¢è°å¡ãæ訴ã¸ãé¸æãã©ã«ã³ã¹ã¿ã¤ãã®éç§å¦ç主張ãçéã§ãã Meiji Seika ãã¡ã«ãã¯10æ24æ¥ãç«æ²æ°ä¸»å ã®åå£ä¸ååè¡é¢è°å¡ãåèªæ£æã§æ訴ããæ¹éãåºããã27æ¥æé票ã®è¡é¢é¸å¾ãæ±äº¬å°è£ã«æ°äºè¨´è¨ãèµ·ãããåå£æ°ã¯ãMeiji Seikaã製é 販売ããã¬ããªã³ã³ã¿ã¤ãï¼èªå·±å¢å¹ åï¼ã®æ¬¡ä¸ä»£mRNAã¯ã¯ãã³ã»ã³ã¹ã¿ã¤ãã«ã¤ãã¦ãé¸æåããéç§å¦çãªä¸»å¼µãç¹°ãè¿ãã¦ããããããã«é¸æéåç¨ãã©ãé¸æå ¬å ±ã§ã³ã¹ã¿ã¤ããã¯ããã¨ããã¬ããªã³ã³ã¯ã¯ãã³ã¯ãæ²»é¨ãããã¢ã¡ãªã«ã§ããããã ã§ãèªå¯ããã¦ããªãæªç¥ã®ã¯ã¯ãã³ãã§ãããæ¥æ¬äººããã¢ã«ã¢ããã«ããã¦ããã¨è¨ã£ã¦ãéè¨ã§ã¯ãªããã¨è¨è¼ã»ä¸»å¼µãããMeiji Seikaã¯ãåå£æ°ã®ããã¾ã§ã®è¨åãå«ããæªæã®ããåèªæ£æã«ãããã¨å¤æããã âMeiji Seika åºå ±ã»æ¸å¤é¨
ç«ãæ»ãã ã ã¾ã å®å®¶ã«ããé ãå¤ã®é¨ã®å¤ã«è£åºã®ç¶²æ¸è¶ãã«å¿ æ»ã«ãªãã¦å©ããæ±ãã«ãããéè¯ç«ã§ã¯ãªããããªæ¯ã®é·ã種é¡ã®ç«ã§è骨ãã´ãªã´ãªã¨ç©ãã¦ãããæ¢ã«ç«ã2å¹é£¼ã£ã¦ããã®ã§æã£ã¦ãããã³ã¨ãµãããã«ããããã¬ãªã¬ãªãªã®ã«ããããé£ã¹ãã«ãããã¯ãã 人æããã£ã¦æ«ã§ã¦ããã¨å¿ æ»ã«ããã¿ç¶ããææ ã«é£¢ããç«ã ã£ãã ãã®ï¼ãï¼å¹´å¾ã以åã絶対ã«äººã«å¯æãããã¦ããã§ããã人æããéè¯ç«ããè·å ´ãããã¡ã«æãããè·å ´ã§åãç£ã¿ãåãããããã§å¼ãåã£ãããåãåãããã«ããã¯ã¨ã¦ãæ²ããã£ã¦è¦ã¦ããããªãã£ããããã«ããã¯ææ 表ç¾ãè±ãã§ãç§ã帰ã£ã¦ããã¨ãçé¢ã®åéã§ã°ã£ããã°ã£ããã¨èº«ä½ãããããããããè¨ããªããåã³ãå ¨èº«ã§è¡¨ç¾ãããç§ãä»ã®ç«ãæ«ã§ã¦ããã¨ä¸æ©å«ãªé¡ãããªãããã³ãã§è¿½ãæããç§ãç¬ãå ããããã¨ããå«å¦¬æ·±ãã人ä¸åã ã£ãã æ³ãåã£ããã®ï¼äººã¯æ¯æ¥å¯ãæ·»ã£ã¦å¯
åçå´åçã¯31æ¥ãç¾å®¹ç®çãªã©ã§ãã¨ã¯ã½ã½ã¼ã ãã¨å¼ã°ããç´°èã®åæ³ç©ã使ã£ãèªç±è¨ºçãåºãã£ã¦ãããã¨ãåããããã§ä½¿ããã製åã«ã¯å½ã®è¬äºæ¿èªãåããå»è¬åã¯ãªããå®å ¨æ§ãªã©ã確èªããã¦ããªãã¨æ³¨æåèµ·ãããé½éåºçãªã©ã«å¯¾ããå¹æå¹è½ãããããããªè£½åã®åºåã販売ã¸ã®æå°ãåãç· ã¾ããå¾¹åºããããè¦è«ããã åå´çã¯ï¼1ï¼ã¨ã¯ã½ã½ã¼ã ãç æ°ã®æ²»çç®çã«ä½¿ç¨ã§ããã¨ç¤ºãã¦ããï¼2ï¼æ¿èªãããå»è¬åã¨èª¤èªãããï¼3ï¼å»è¬åã®ãããªå¹æå¹è½ã説æãã¦ããâã¨ãã£ã製åããã£ãå ´åã«ãèªæ²»ä½ãæå°ãè¡ãã¨ããã å»çæ©é¢åãã«ã¯ãã¨ã¯ã½ã½ã¼ã ãªã©ãç¨ããèªç±è¨ºçãããå ´åã«ã¯ãæ¥æ¬åçå»çå¦ä¼ãå質ããªã¹ã¯ã®ç®¡çã«ã¤ãã¦ã¾ã¨ããæå¼ãåèã«å®å ¨ãªå®æ½ã«åªããããå¼ã³ãããã ã¨ã¯ã½ã½ã¼ã ã¯ãç´°èããåæ³ãããå¾®ç²åãç æ°ã®æ²»çã«å¿ç¨ããç 究ãå½å å¤ã§é²ãä¸æ¹ãæä¸ã«ãã£ã¦èåé²æ¢ãèçã®ç
å®é¸ãã¼ã ãã¼ã¸ã®è³æã«ãã·ã§ãã£ã³ã°ã®æ¸å¿µã¯æè¨å ã ã·ã§ãã£ã³ã°ã¯çã¯ã¯ãã³ãä»è ã«ä¼æãææããç¾è±¡ éºä¼åæ²»çãåããæ£è ã®ããã®ã¦ã¤ã«ã¹/ãã¯ã¿ã¼ã®æåºãã·ã§ãã£ã³ã°ã¨å®ç¾©ã家æãå»çå¾äºè ã¸ä¼æãæ¸å¿µ ãã©ã¹ãããã¯ã¿ã¼ã§ãæ¸å¿µäºé ã§ããã®ã§DNAæ±æã§ãåé¡ã« å³ã¯é¦ç¸å®é¸ãã¼ã ãã¼ã¸ã®è³æ[1]ã«èµ¤ã§æ³¨é å ã ãã·ã§ãã£ã³ã°ã¯çã¯ã¯ãã³ãæ¥ç¨®ããã人ããæ¡æ£ããç¾è±¡ãæããçµæãä»ã®äººã«ä¼æ(transmission)ãããã¨ããããçã¯ã¯ãã³ã¯å¼±æ¯åããããç¡æ¯åãããã¦ã¤ã«ã¹ã§ãããããä¼æãææããã¨ããæ§è³ªãå¿ ãããç¡ããªã£ã¦ããããã§ã¯ç¡ãããã®ããèµ·ããå¾ãç¾è±¡ã§ããã éºä¼å製å¤ã«ãããã·ã§ãã£ã³ã°ã¯å½ãèªãããªã¹ã¯ã§ãããé¦ç¸å®é¸ãã¼ã ãã¼ã¸ã«å½ç«å»è¬åé£åè¡çç 究æã®è³æ[1]ãç½®ãã¦ããããã®ä¸ã§ãéºä¼åæ²»çãåããæ£è ã®ããã®ã¦ã¤ã«ã¹ããã¯ã¿ã¼ã®æåº(s
æ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ããå復ããå¾ãç²å´æãæ¯åããçåã®ä½ä¸ã¨ãã£ããã¾ãã¾ãªçç¶ãç¶ããã³ã°COVIDã«ãã£ã¦ãä»äºãæ¥å¸¸çæ´»ãªã©ã«å½±é¿ãçããã±ã¼ã¹ãå ±åããã¦ãã¾ããã«ãªãã©ã«ãã¢å¤§å¦ãµã³ãã©ã³ã·ã¹ã³æ ¡ãªã©ã®ç 究ãã¼ã ãCOVID-19ããå復ããæ£è ã®å ¨èº«ã¹ãã£ã³ãå®æ½ããã¨ãè³å¹¹ãèé«ã骨é«ãªã©ã®çµç¹ã«Tç´°èã®ç°å¸¸ãªæ´»æ§åã確èªããã¾ããã Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection | Science Translational Medicine https://www.science.org/doi/10.1126/scitranslmed.adk3295 COVID's Hidden Toll: F
å°å ããæ£è ã«æä¸ãããæããå¤ã®æåããå ¥é¢ä¸ã«ä»ãæ·»ã家æã®å°¿ããæ¤åºãããäºä¾ã確èªãããæ¥æ¬å°å ããçè·å¦ä¼ãå®å ¨å¯¾çã®æéã¥ãããé²ãã¦ãããã¨ãããã£ãã調æ»ã§ç¢ºèªããä¹å·å¤§ã第ä¸è¬ç§å¤§ãªã©ã®ãã¼ã ã¯ãæ£è ã®å°¿ãæ±ãªã©ãä»ãã家æã®ä½å ã«åãè¾¼ã¾ããã¨ã¿ã¦ããã ãä¸è¦§è¡¨ãå°å ããã®ä¸»ãªæ©æåä½µç 第ä¸è¬ç§å¤§ã®éç°åªåè¬å¸«ï¼çè·å¦ï¼ãã¯ã2019å¹´ã¾ã§ã«å°å ãã診çãè¡ãç é¢ã§èª¿æ»ãå®æ½ãæããå¤ã»ã·ã¯ããã¹ãã¡ããã«ããåå¦çæ³ãåããæ£è ã®ä»ãæ·»ã家æ15人ãå»çå¾äºè 21人ã«ã¤ãã¦ãæããå¤æä¸ãã6æéå¾ã«å°¿ãæ¡åããåæããã ãã®çµæã乳幼å ã®å®¶æ7人ã®ãã¡6人ãå°ä¸å¦çã®å®¶æ8人ã®ãã¡2人ããæããå¤ã®æåãæ¤åºããããæä¸éã¯å°ä¸å¦çãã乳幼å ãå°ãªãã£ããã家æããã®æ¤åºéã¯ä¹³å¹¼å ãå¤ãã£ããä¸æ¹ãå»çå¾äºè ããã¯æ¤åºãããªãã£ããæ£è ã«æ¥ããéãªã©ã«æé²å¯¾ç
ã¢ãã«ã§ã¿ã¬ã³ãã®å®æææ¥ï¼ï¼ï¼ï¼ããï¼æ¥æ¾éã®æ¥æ¬ãã¬ãç³»ãã«ãºã¬ã¼ã¶ã¼ã¨å¦ã¶ãè¶ ææ°å¥åº·è¨ºæã§è¸è½äººã®ä½ãé ã ã¾ã§å¾¹åºæ¤æ»ï¼³ï¼°ãã«åºæ¼ãèªèº«ã®ä½ãã大éã«åºã¦ããã¨ããâã«ã¡ã ã·èâã«ã·ã§ãã¯ãåããã ãåçãã«ã¡ã ã·èãªããããªããããªãç¾ããè¼ãå®æææ¥ã®ãã³ã«ã⥠çªçµã§ã¯åºæ¼è ãã¡ã®ç®èããçºããããï¼ç¨®é¡ã®ã¬ã¹ãåæããä½èãæ¤è¨¼ããã®ä¸ã§ãã«ã¡ã ã·ã®èãã«å«ã¾ããæåã§ã常å¨èãç®èãå解ããçµæã§çºçãããï¼ï¼ããã»ãã¼ã«ãã®éã測å®ããã¨ãããå¹³åå¤ãï¼ã»ï¼ãªã®ã«å¯¾ããå®æã®æ°å¤ã¯ç´ï¼åã¨ãªãï¼ã»ï¼ãçµæã®çºè¡¨ãè¦ãªããå®æã¯ç¬ããªããããããããããï¼ãã¨æ²é³´ãä¸ããã å®æã¯ããã«ãèªèº«ã®æ°å¤ãä¿¡ããããªãæ§åã§ãé¡ãæãããªãããã¡ãã£ã¨å¾ ã£ã¦ï¼ãã£ãï¼ãã¨å³ãã表æ ãæ±æµ·å¤§å¦çå¦é¨ã®é¢æ ¹åé¦ææã«ãã¡ãã£ã¨è¥å¹²é«ãã§ããã©ããç®èã®åæ³éã¯ï¼ï¼ä»£å¾åããï¼ï¼ä»£
å æ¥ãä¸å®ãã«ã¤ãã¦ããã°ãæ¸ããã°ããã§ãããä»åã®ãã¿ã¯ä¸å®ãç ½ã£ã¦ãã¾ããã®ããããã¾ããã ãããç¾å®ã«èµ·ãã£ã¦ãããã¨ãªã®ã§ãããã¯æ å ±å ±æãã¦ãããã¨æãã¾ãã ãèªåã®èº«ãå®ããããã«ã§ãã èªåã¯ããã¾ã§è¨ªå診çã16å¹´ãã£ã¦ãã¾ããã ããã¾ã§ã®èªåã®ã¦ãªï¼ã¯ãæ£è ãããæ»ãªãªããã¨ãã ã£ãã®ã§ãã ã¼ãã§ã¯ãªãã§ããã ãæ£è ããããªããªãæ»ãªãªããã¨ããæ¬æ¥ã®æ£ããè¨èã§ã¯ããã®ã§ããããªãã ãããªããªãæ»ãªãªããã¨æ¸ãã®ãã¢ã¬ãªã®ã§â¦ã 以åéããã¦åãã¦ãã訪å診çã¯ãªããã¯ã§ããä»ã®å çã¯çåããçµæ§ããã®ã«ãèªåã®æ å½æ£è ããã§ã¯çåãã¯ã»ã¨ãã©ããã¾ããã§ããã éæ¥ãã¦ããããçåãã¯å¹´ã«2ï½3件ãããã§ããã å¹´ã«3件ãããã°ãå¤ããªããã¨æãããããã§ããã ã¡ãªã¿ã«ã2009å¹´æ°åã¤ã³ãã«ã¨ã³ã¶ã話é¡ã«ãªã£ãã¨ãããã®å¹´ãé«é½¢è ãåªå ãã¦æ°åã¤ã³ãã«
Netherlands: Woman (63 years old) dies from blood clots 5 days after transfusion Emser, 63, died from blood clots in her lungs and legs five days after receiving a blood transfusion. The Other Newspaper wrote that the incident was reported to Sanquin but the blood bank suppressed⦠pic.twitter.com/AUP1wdQBbt â Camus (@newstart_2024) June 10, 2024 ãªã©ã³ãï¼å¥³æ§ï¼63æ³ï¼ã輸è¡5æ¥å¾ã«è¡æ ã§æ»äº¡ 63æ³ã®ã¨ã ãµã¼ããã¯ã輸è¡ãåãã5æ¥å¾ã«èºã¨èã®è¡
ãçä¾ã40ä»£å¥³æ§ ã主訴ãåå®®ã®çã¿ ãç¾ç æ´ãã«ã¤ãã¦ã¯ãæ¬äººã®è¨èã§èªã£ã¦ããããã ãå æãããã§ã¢ã¤ã¹ã¯ãªã¼ã ãè²·ã£ãã®ã§ããããããé£ã¹ãå¾ããã«ãå·¦ã®ããã®ä¸ãçããªã£ã¦ãããã«ãé¦ã®ä¸ãé¼ å¾é¨ããã¡ãã¡ãçããªã£ããè¦ããã«ãå ¨èº«ã®ãªã³ãç¯ãçããªãã¾ãããç¶ãã¦ã横éèããããããããããªéåæãèµ°ããèèããã·ãã¨ã·ã§ãã¯ãåãããããªæè¦ããã£ã¦ããã®å¾ãåµå·£ã¨åå®®ãçããªã£ã¦ãããåå®®ãçããããã«çãã¦ãã»ã¡ã³ããæµãè¾¼ã¾ããããã«ã«ãã«ãã«ãªã£ãã ç§ãåºæ¬çã«å¥åº·ã§ãä½ã®å¤åã«ã¯ãããææãªã»ãã§ããããã§ãã¢ã¤ã¹ãåå ã ã¨ããã«æ°ä»ãã¾ããããé£ä¸æ¯ãªãã¦çãããããã®ãããªãããã£ã¨ä½ããå±éºãªãã®ã ã¨ç´æãã¾ããã ã³ããã¯ã¯ãã³ã®ãã¨ã¯åãã£ã¦ãã¾ããæã£ã¦ãªãã®ã¯ãã¡ãããã¯ã¯ãã³é¢é£ã®æ¸ç±ãèªãã§ããã®ã§ããã®æã®ç¥èã¯ãã£ããããã»ãã ã¨æãã¾ã
ã·ã§ãã£ã³ã°ã«ã¤ãã¦ããã¯ãããæè¿ãã£ããã«ãªã£ã¦ãã¦ããæã¯ããã¾ãã ããã¾ã§æ¸ããã¨ãããèªåã®å ´åã¯æãã¦ãããã«æ¹åãã¦å¼ããããã¨ã¯ãã¾ããªããªã£ãã®ã§ãããæ°´ä¸ç¢ã®è©±ã¨ãå¨å²ããã¯ããèãã¾ããã ããã¦ä½ãããããªã¤ãã§ãã æè¿æã£ãã¨ããããªã¯ãã§ã¯ãªãã®ã«ãè¶ å¼·çã«ããªã¤ãçºããæ¹ãæã ãã¾ãã æè¦çã«ãã¤ãããã¬ãã«ã®ããªã¤ã®ãªã®ã§ããåºããããªããªã¤ã¨ã§ãè¨ãã®ãã ã§ãæã ã·ã§ãã£ã³ã°ã«ã¤ãã¦ãæ°ã®æã¡ãããã¨ããæ¹ãããã£ãããã¾ãã ã·ã§ãã£ã³ã°ã«ãã©ã¼ã«ã¹ããããããããçç¶ãåºãã®ã ã¨ã ããã¾ã§ä½äººããããã®ãããªã話ã伺ãã¾ããã 確ãã«ãç ã¯æ°ãããã¨è¨ãã¾ãã ã·ã§ãã£ã³ã°ã¨ãããã®ã«ã¨ããããããã®ãè¯ããªãã¨ããã¯ããã§ãããã ãããã¯ã£ããè¨ã£ã¦ãã·ã§ãã£ã³ã°ã¯ãæ°ã®æã¡ãããã®åé¡ã§ã¯æ±ºãã¦ããã¾ããã ãã¡ã¤ã¶ã¼ã®æ²»é¨ãããã³ã«ã®
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}